Acute lymphoblastic leukaemia

L Pagliaro, SJ Chen, D Herranz, C Mecucci… - Nature Reviews …, 2024 - nature.com
Acute lymphoblastic leukaemia (ALL) is a haematological malignancy characterized by the
uncontrolled proliferation of immature lymphoid cells. Over past decades, significant …

The JAK/STAT signaling pathway: from bench to clinic

X Hu, J Li, M Fu, X Zhao, W Wang - Signal transduction and targeted …, 2021 - nature.com
The Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling
pathway was discovered more than a quarter-century ago. As a fulcrum of many vital cellular …

Interferon-gamma at the crossroads of tumor immune surveillance or evasion

F Castro, AP Cardoso, RM Gonçalves, K Serre… - Frontiers in …, 2018 - frontiersin.org
Interferon-gamma (IFN-γ) is a pleiotropic molecule with associated antiproliferative, pro-
apoptotic and antitumor mechanisms. This effector cytokine, often considered as a major …

Therapeutic advances of targeting receptor tyrosine kinases in cancer

C Tomuleasa, AB Tigu, R Munteanu… - … and Targeted Therapy, 2024 - nature.com
Receptor tyrosine kinases (RTKs), a category of transmembrane receptors, have gained
significant clinical attention in oncology due to their central role in cancer pathogenesis …

Integrated genomic characterization of pancreatic ductal adenocarcinoma

Cancer Genome Atlas Research Network - Cancer cell, 2017 - pmc.ncbi.nlm.nih.gov
We performed integrated genomic, transcriptomic and proteomic profiling of 150 pancreatic
ductal adenocarcinoma (PDAC) specimens, including samples with characteristic low …

The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia

Y Liu, J Easton, Y Shao, J Maciaszek, Z Wang… - Nature …, 2017 - nature.com
Genetic alterations that activate NOTCH1 signaling and T cell transcription factors, coupled
with inactivation of the INK4/ARF tumor suppressors, are hallmarks of T-lineage acute …

Tumor mutational burden as a predictive biomarker for response to immune checkpoint inhibitors: a review of current evidence

SJ Klempner, D Fabrizio, S Bane, M Reinhart… - The …, 2020 - academic.oup.com
Abstract Treatment with immune checkpoint inhibitors (ICPIs) extends survival in a
proportion of patients across multiple cancers. Tumor mutational burden (TMB)—the number …

Integrated genomic characterization of pancreatic ductal adenocarcinoma

BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh… - Cancer cell, 2017 - cell.com
We performed integrated genomic, transcriptomic, and proteomic profiling of 150 pancreatic
ductal adenocarcinoma (PDAC) specimens, including samples with characteristic low …

IL-7: comprehensive review

H Winer, GOL Rodrigues, JA Hixon, FB Aiello, TC Hsu… - Cytokine, 2022 - Elsevier
Overview IL-7 is a member of the family of cytokines with four anti-parallel α helixes that bind
Type I cytokine receptors. It is produced by stromal cells and is required for development …

The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours

SJ Thomas, JA Snowden, MP Zeidler… - British journal of …, 2015 - nature.com
Aberrant activation of intracellular signalling pathways confers malignant properties on
cancer cells. Targeting intracellular signalling pathways has been a productive strategy for …